Turnstone Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.13	17.8	34.73	123.38
Short-Term Investments	21.15	76.98	47.33	37.64
Cash & Short-Term Investments	45.28	94.78	82.06	161.02
Cash Growth	-58.50%	15.50%	-49.04%	-
Receivables	-	0.19	8.73	6.72
Prepaid Expenses	3.71	4.66	5.08	9.23
Restricted Cash	0.12	0.12	0.38	0.38
Other Current Assets	2.03	2.81	1.75	-
Total Current Assets	51.14	102.55	98	177.34
Property, Plant & Equipment	6.47	9.12	14.36	9.37
Other Long-Term Assets	0.87	1.14	2.58	0.54
Total Assets	58.48	112.82	114.94	187.24
Accounts Payable	0.56	0.04	3.44	0.03
Accrued Expenses	11.64	9.91	10.22	14.03
Current Portion of Leases	1.44	2.03	1.96	0.66
Current Income Taxes Payable	-	-	-	0.25
Current Unearned Revenue	-	-	15.14	33.03
Other Current Liabilities	-	-	4.06	6.97
Total Current Liabilities	13.64	11.97	34.83	54.98
Long-Term Leases	0.26	1.19	3.21	2.02
Long-Term Unearned Revenue	-	-	4.16	39.37
Other Long-Term Liabilities	0.94	0.99	2.27	0.97
Total Liabilities	14.84	14.15	44.46	97.34
Common Stock	0.02	0.02	0	0.02
Additional Paid-In Capital	278.54	275.52	20.5	9.1
Retained Earnings	-234.72	-176.76	-121.56	-90.72
Comprehensive Income & Other	-0.2	-0.12	-0.41	-0.25
Total Common Equity	43.64	98.67	-101.47	-81.85
Shareholders' Equity	43.64	98.67	70.48	89.9
Total Liabilities & Equity	58.48	112.82	114.94	187.24
Total Debt	1.7	3.21	5.17	2.68
Net Cash (Debt)	43.59	91.56	76.9	158.34
Net Cash Growth	-58.66%	19.08%	-51.44%	-
Net Cash Per Share	1.89	7.92	30.95	58.65
Filing Date Shares Outstanding	23.13	23.1	3.03	2.15
Total Common Shares Outstanding	23.13	23.1	2.92	2.15
Working Capital	37.5	90.58	63.17	122.37
Book Value Per Share	1.89	4.27	-34.80	-38.08
Tangible Book Value	43.64	98.67	-101.47	-81.85
Tangible Book Value Per Share	1.89	4.27	-34.80	-38.08
Machinery	-	11.73	14.04	5.93
Construction In Progress	-	-	-	2.94
Leasehold Improvements	-	1.31	1.31	1.31

Source: S&P Capital IQ. Standard template. Financial Sources.